JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
Monday, July 30, 2018
The Dermatologist spoke with Adam Friedman, MD, FAAD, professor of dermatology at George Washington School of Medicine and Health Science and director of the supportive oncodermatology clinic, about supportive oncodermatology and its role in cancer treatment.
Monday, July 2, 2018
This article describes the current federal policy debate regarding compounding and offers suggestions on how physicians can make their voices heard.
Wednesday, November 29, 2017
Lawrence Eichenfield, MD, reports on major developments in the changing field of pediatric dermatology.
Tuesday, October 3, 2017
In the current managed care environment, it is harder for dermatologists to place their patients on what they feel is the best choice medication for each patient.
Wednesday, August 30, 2017
Yolanda R. Helfrich, MD, discusses exciting developments in rosacea research, as well as what inspired her to specialize in the field.
Friday, March 3, 2017
Dr Gelfand discusses the evolving landscape of psoriasis research and a multidisciplinary perspective to treating patients who present with inflammatory conditions in multiple organ systems.
Wednesday, December 28, 2016
Here is a look at the good (new technology) and the bad (more fees) in the coming year.
Tuesday, November 1, 2016
Large dermatology practices and private equity firms are acquiring practices with increasing regularity. The impact of what it will mean for the specialty in the long run is not yet known.